Why Genworth Mortgage Insurance Australia Ltd shares are bottoming out

Shares in lenders mortgage insurance player Genworth Mortgage Insurance Australia Ltd (ASX: GMA) have been tracking down for the past year

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in lenders mortgage insurance player Genworth Mortgage Insurance Australia Ltd (ASX: GMA) have been tracking down for the past year, dropping from $3.13 to $2.31 at the time of writing.

It's likely a few things have contributed to Genworth's share price demise in the recent past.

To start with its profits took a huge hit when banks changed their lenders mortgage insurance parameters and capped their loan to valuation ratios so demand for lenders mortgage insurance itself dropped.

Genworth's policy to pay out 50% to 80% of underlying NPAT as dividends also hasn't helped them weather any sector storms, with a reduced, but very tasty, dividend tipped for 2018.

A note out of Macquarie last month saw analysts retain their outperform rating for Genworth, placing a $3.50 price target on the stock which some investors may have seen as a short-term buy opportunity, with Macquarie speculating the market is acting like there is a housing market crisis in terms of how its priced the stock, when there is no such volatility expected in the sector at all – although house prices have been flat.

Peer Mortgage Choice Limited (ASX: MOC) hasn't fared much better over the same period with share prices in the mortgage broking company dropping from $2.28 at this time last year to $1.76 today.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »